Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry

Antiviral Research

Volumn 100, Issue 2, 2013, Pages 399-406

  Nasser, Zainab H ^a   Swaminathan, Kavya ^a   Müller, Patrick ^a   Downard, Kevin M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antiviral inhibitor; Arbidol; Gel electrophoresis; Hemagglutinin; Influenza virus

Indexed keywords

ARBIDOL; INFLUENZA VIRUS HEMAGGLUTININ; ANTIVIRUS AGENT; HEMAGGLUTININ; INDOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; GEL ELECTROPHORESIS; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; VIROGENESIS; ANIMAL; ANTIVIRAL INHIBITOR; CELL LINE; CHEMICAL STRUCTURE; DRUG EFFECT; ENZYMOLOGY; INFLUENZA VIRUS; MASS SPECTROMETRY; METABOLISM; ORTHOMYXOVIRUS; PROTEIN BINDING;

ORTHOMYXOVIRIDAE;

ANTIVIRAL INHIBITOR; ARBIDOL; GEL ELECTROPHORESIS; HEMAGGLUTININ; INFLUENZA VIRUS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INDOLES; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; ORTHOMYXOVIRIDAE; PROTEIN BINDING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84885353517     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.08.021     Document Type: Article

References (32)

1. J.M. Barry The great influenza: the story of the deadliest pandemic in history 2006 Penguin Books New York
2. D. Birnkrant, and E. Cox Emergency use authorization of peramivir New Engl. J. Med. 361 2009 2204 2207
3. Y.S. Boriskin, I.A. Leneve, and E.I. Pecheur Arbidol, a broad-spectrum anti-viral that blocks viral fusion Curr. Med. Chem. 15 2008 997 1005
4. N.M. Bouvier, and P. Palese The biology of influenza viruses Vaccine 26 2008 D49 53
5. R.B. Couch Prevention and treatment of influenza New Engl. J. Med. 343 2000 1778 1787
6. T.G. Fanning, and J.K. Taubenberger Phylogenetically important regions of the influenza A H1 hemagglutinin protein Virus Res. 65 1999 33 42
7. S.J. Gamblin, L.F. Haire, R.J. Russell, D.J. Stevens, B. Xiao, Y. Ha, N. Vasisht, D.A. Steinhauer, R.S. Daniels, A. Elliot, D.C. Wiley, and J.J. Skehel The structure and receptor binding properties of the 1918 influenza hemagglutinin Science 303 2004 1838 1842
8. A.W. Hampson, and J.S. Mackenzie The influenza viruses Med. J. Aust. 185 2006 S39 S43
9. S.H. Hauge, S. Dudman, K. Borgen, A. Lackenby, and O. Hungnes Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-2008 Emerg. Infect. Dis. 15 2009 155 162
10. J.W.K. Ho, B. Morrissey, and K.M. Downard A computer algorithm for the identification of protein interactions from the spectra of masses (PRISM) J. Am. Soc. Mass Spectrom. 18 2007 563 566
11. A.C. Hurt, J.K. Holien, M.W. Parker, and I.G. Barr Oseltamivir resistance and the H274Y neuraminidase mutation Drugs 69 2009 2523 2531
12. E.D. Kilbourne Influenza pandemics of the 20th century Emerg. Infectious Dis. 12 2006 9 14
13. J.G. Kiselar, and K.M. Downard Antigenic surveillance of the influenza virus by mass spectrometry Biochemistry 43 1999 14185 14191
14. I.A. Leneva, N.I. Fadeeva, and I.T. Fedyakina The study of effect of a new antiviral drug arbidol on different stages of viral reproduction Antiviral Res. 23 1994 187 199
15. I.A. Leneva, R.J. Russell, and Y.S. Boriskin Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol Antiviral Res. 81 2009 132 140
16. C. Li, M. Shao, X. Cui, and Y. Song Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China Biologicals 38 2010 284 289
17. B. Morrissey, and K.M. Downard A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry Proteomics 6 2006 2034 2041
18. B. Morrissey, M. Streamer, and K.M. Downard Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry J. Virol. Methods 145 2007 106 114
19. A. Moscona Neuraminidase inhibitors for influenza New Engl. J. Med. 353 2005 1363 1373
20. A. Moscona Global transmission of oseltamivir-resistant influenza N. Engl. J. Med. 360 2009 953 956
21. M.S. Pereira The effects of shifts and drifts on the epidemiology of influenza in man Phil. Trans. Royal Soc. Lond. Biol. Sci. 288 1980 423 432
22. G.A. Poland, S.T. Rottinghaus, and R.M. Jacobson Influenza vaccines: a review and rationale for use in developed and underdeveloped countries Vaccine 19 2001 2216 2220
23. A.B. Schwahn, and K.M. Downard Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays J. Immunoassay Immunochem. 30 2009 245 261
24. L. Shi, H. Xiong, and J. He Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo Arch. Virol. 152 2007 1447 1455
25. K. Subbarao, and J. Katz Avian influenza viruses infecting humans Cell. Mol. Life Sci. 57 2000 1770 1784
26. K. Swaminathan, and K.M. Downard Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry Anal. Chem. 84 2012 3725 3730
27. K. Swaminathan, J.C. Dyason, and A. Maggioni Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry Anal. Bioanal. Chem. 405 2013 6563 6572
28. C.J. Vavricka, Q. Li, Y. Wu, and J. Qi Structural and functional analysis of laninamivir PLoS Pathog. 7 2011 e1002249
29. M. Von Itzstein, and R. Thomson Anti-influenza drugs: the development of sialidase inhibitors Handb. Exp. Pharmacol. 189 2009 111 154
30. J. Wilschut, J. Mcelhaney, and A. Palache Rapid Reference to Influenza second ed. 2006 Mosby-Elsevier Netherlands
31. World Health Organization, 2009. Influenza fact sheet No. 211, http://www.who.int/mediacentre/factsheets/fs211/en/.
32. World Health Organization,2010, Oseltamivir resistance, Weekly Update (August).